Table 2 Clinical outcomes of included studies
Author | Year | Therapies | Hips | Hips to THA | Hips with RP | Staging methods | Complications | Follow-up (month) |
|---|---|---|---|---|---|---|---|---|
Gangji | 2011 | Control: CD Trial: CD+Marrow | Control: 11 Trial: 13 | Control: 3 Trial: 2 | Control: 8 Trial: 3 | ARCO | Pain: 4 Infection: 1 | 60 |
Zhao | 2012 | Control: CD Trial: CD+Marrow | Control: 44 Trial: 53 | Control: 5 Trial: 2 | Control: 10 Trial: 2 | ARCO | None | 60 |
Pepke | 2016 | Control: CD Trial: CD+Marrow | Control: 14 Trial: 11 | Control: 6 Trial: 4 | Control: 6 Trial: 4 | ARCO | NA | 24 |
Zhang HJ | 2010 | Control: CD Trial: CD+Marrow | Control: 15 Trial: 24 | NA | Control: 2 Trial: 1 | ARCO | None | 18 |
Zhuo NQ | 2012 | Control: CD Trial: CD+A.B | Control: 12 Trial: 21 | Control: 4 Trial: 1 | Control: 4 Trial: 1 | Ficat | None | 30 |
Guo HS | 2018 | Control: CD Trial: CD+A.B | Control: 41 Trial: 35 | NA | Control: 6 Trial: 1 | Ficat | Pain: 1 | 30 |
Warner | 1987 | CD | 39 | 19 | 23 | Ficat | Fracture: 1 Hematoma: 1 | 16 |
Tooke | 1988 | CD | 45 | 16 | 16 | Ficat | Fracture: 1 | 36 |
Lausten | 1990 | CD | 29 | 15 | 11 | Ficat | Pain: 1 | 17.2 |
Learmonth | 1990 | CD | 41 | 18 | 34 | Ficat | Fracture: 1 | 32 |
Fairbank | 1994 | CD | 128 | 55 | 81 | Ficat | Fracture: 4 Perforation of femoral head: 1 Deep venous thrombosis: 2 Retained drain: 1 | 132 |
Smith | 1995 | CD | 114 | 64 | 81 | Ficat | Infection: 3 Fracture: 2 Hematoma: 2 Non-fatal pulmonary embolism: 1 Deep venous thrombosis: 1 Reflex sympathetic dystrophy: 1 | 40 |
Markel | 1996 | CD | 54 | 26 | NA | Ficat | Fracture: 2 Infection: 1 | 27.1 |
Mont | 1997 | CD | 79 | 37 | 37 | Ficat | NA | 144 |
Powell | 1997 | CD | 34 | 6 | 9 | Ficat | None | 48 |
Iorio | 1998 | CD | 33 | 11 | 17 | Ficat | NA | 60 |
Bozic | 1999 | CD | 54 | 28 | 34 | Ficat | Fracture: 1 Hematoma: 1 | 97 |
Steinberg | 2001 | CD+A.B | 312 | 113 | 113 | UPSS | NA | 48 |
Hernigou | 2002 | CD+Marrow | 189 | 34 | 52 | Ficat | Pain: 1 Pneumonia: 1 Alloimmunization: 1 | 84 |
Lieberman | 2004 | CD | 17 | 3 | 3 | Ficat | Pain: 4 | 53 |
Belmar | 2004 | CD | 302 | 113 | NA | UPSS | NA | 46 |
Song | 2007 | CD | 163 | 50 | NA | Ficat | Heterotopic ossifications: 23 Fracture: 1 | 87 |
Li YP | 2007 | CD+A.B | 36 | 4 | 4 | ARCO | NA | 23.4 |
Ji WF | 2008 | CD+Marrow | 103 | NA | NA | UPSS | None | 26 |
Xu WH | 2009 | CD+A.B | 42 | NA | NA | Ficat | None | 38 |
Wang | 2010 | CD+Marrow | 59 | 7 | 14 | ARCO | NA | 27.6 |
Cao B | 2010 | CD+A.B | 61 | NA | 22 | Ficat | NA | 26.4 |
Yang J | 2010 | CD | 85 | 6 | 19 | UPSS | None | 57.6 |
Zhao Y | 2011 | CD | 25 | 2 | NA | Ficat | NA | 73 |
Chotivichit | 2012 | CD+Marrow | 11 | 2 | 8 | Ficat | NA | 42.6 |
Chotivichit | 2014 | CD+Marrow | 34 | 10 | 9 | Ficat | Pain: 4 | 25.8 |
Chen XT | 2015 | CD+A.B | 58 | 11 | 11 | ARCO | NA | 34.05 |